The analysis focuses on HIMS & Hers (HIMS) and its recent performance. Despite a nearly 40% stock price decline over the last six months, analysts have lowered their free cash flow expectations. However, the company has shown significant revenue growth, projecting $2.3 billion in revenue for 2025 and $298 million in 2027. Free cash flow to sales has improved, turning positive for two consecutive years and increasing to 17% in the most recent trailing twelve months. The forward P/E is trading near the midpoint of its historical range. The current intrinsic value per share is estimated at $31.68, down from a previous estimate of around $39, while the current market price is $31.32. Analysts have a 'Buy' rating on HIMS, suggesting it's a buying opportunity at current levels.